Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.
At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.
At AMP’s annual meeting, the organization also honored Alexis Carter, Dara Aisner, and Lawrence Jennings for their contributions to laboratory medicine and molecular pathology.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.
Opioid settlement funds were used for R&B concerts promoting addiction awareness in Irvington, New Jersey, highlighting broader debates over how opioid restitution money is spent nationwide.